학술논문

Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study
Document Type
Article
Author
Chanchlani, NeilLin, SimengBewshea, ClaireHamilton, BenjaminThomas, AmandaSmith, RebeccaRoberts, ChristopherBishara, MariaNice, RachelLees, Charlie WSebastian, ShajiIrving, Peter MRussell, Richard KMcDonald, Timothy JGoodhand, James RAhmad, TariqKennedy, Nicholas APatel, VinodMazhar, ZiaSaich, RebeccaColleypriest, BenTham, Tony CIqbal, TariqKaushik, VishalMurugesan, SenthilSingh, SalilWeaver, SeanPreston, CathrynButt, AssadSmith, MelissaBasude, DharamveerBeale, AmandaLanglands, SarahDirekze, NatalieParkes, MilesTorrente, FrancoDe La Revella Negro, JuanMacDonald, Chris EwenEvans, Stephen MGunasekera, Anton VJThakur, AlkaElphick, DavidShenoy, AchuthNwokolo, Chuka UDhar, AnjanCole, Andrew TAgrawal, AnuragBridger, StephenDoherty, JulieCooper, Sheldon Cde Silva, ShanikaMowat, CraigMayhead, PhillipLees, CharlieJones, GarethAhmad, TariqHart, James WKennedy, Nicholas AGoodhand, James RLin, SimengChanchlani, NeilNice, RachelMcDonald, Timothy JBewshea, ClaireAl-Nuaimi, YusurRichards, EllenHaigh, RichardGreenish, HuwHeath, HarryGaya, Daniel RRussell, Richard KGervais, LisaDunckley, PaulMahmood, TariqBanim, Paul JRSonwalkar, SunilGhosh, DebPhillips, Rosemary HAzaz, AmerSebastian, ShajiShenderey, RichardArmstrong, LawrenceBell, ClaireHariraj, RadhakrishnanMatthews, HelenJafferbhoy, HasnainSelinger, Christian PZamvar, VeenaDe Caestecker, John SWillmott, AnneMiller, RichardBabu, Palani SathishTzivinikos, ChristosBloom, Stuart LChung-Faye, GuyCroft, Nicholas MFell, John MEHarbord, MarcusHart, AilsaHope, BenIrving, Peter MLindsay, James OMawdsley, Joel EMcNair, AlistairMonahan, Kevin JMurray, Charles DOrchard, TimothyPaul, ThankamPollok, RichardShah, NeilBouri, SoniaJohnson, Matt WModi, AnitaKabiru, Kasamu DawaBaburajan, B KBhaduri, BimFagbemi, Andrew AdebayoLevison, ScottLimdi, Jimmy KWatts, GillFoley, StephenRamadas, ArvindMacFaul, GeorgeMansfield, JohnGrellier, LeonieMorris, Mary-AnneTremelling, MarkHawkey, ChrisKirkham, SianCharlton, Charles PJRodrigues, AstorSimmons, AlisonLewis, Stephen JSnook, JonathonTighe, MarkGoggin, Patrick MDe Silva, Aminda NLal, SimonSmith, Mark SPanter, SimonCummings, JR FraserDharmisari, SurangaCarter, MartynWatts, DavidMahmood, ZahidMcLain, BruceSen, SandipPigott, Anna JHobday, DavidWesley, EmmaJohnston, RichardEdwards, CathrynBeckly, JohnVani, DevenRamakrishnan, SubramaniamChaudhary, RakeshTrudgill, Nigel JCooney, RachelBell, AndyPrasad, NeerajGordon, John NBrookes, Matthew JLi, AndyGore, Stephen
Source
The Lancet Gastroenterology & Hepatology; 20240101, Issue: Preprints
Subject
Language
ISSN
24681253
Abstract
We sought to report the effectiveness of infliximab and adalimumab over the first 3 years of treatment and to define the factors that predict anti-TNF treatment failure and the strategies that prevent or mitigate loss of response.